profit from every $100 of sales.
$0$100
Balchem
$172.35-0.55% today
+9.6% in 1 year
1-year low $147.361-year high $183.26
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2020 to 2025.
0%20% a year
You pay $35.48 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Balchem sold, what it kept, and what it did with the cash.
Sales went from $942 million in 2022 to $1.04 billion in 2025, with $155 million of profit last year.
SalesProfit
Balchem handed back 79% of the cash it generated last year.
Buybacks $108M$28M
Free cash flow 2025$173M
Bought back its own shares$108M
Paid as dividends$28M
Cash vs. debt$75M vs. $181M
Balchem vs. similar companies
Balchem grows the fastest of these 5 and is priced in the middle for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Balchem | 35.5× · Expensive | ||
 Linde | 34.8× · Expensive | ||
 L'Air Liquide | 35.0× · Expensive | ||
 Ecolab | 41.1× · Expensive | ||
 The Sherwin-Williams | 33.1× · Expensive |
AI analysis
An AI analyst reads Balchem's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 704 | 799 | 942 | 922 | 954 | 1,037 | |
| 224 | 243 | 280 | 302 | 336 | 371 | |
| 111 | 128 | 145 | 159 | 183 | 209 | |
| 162 | 176 | 196 | 215 | 231 | 255 | |
| 85 | 96 | 105 | 109 | 128 | 155 | |
| 2.60 | 2.94 | 3.25 | 3.35 | 3.93 | 4.75 | |
| 31.8% | 30.4% | 29.8% | 32.7% | 35.3% | 35.7% | |
| 15.8% | 16.0% | 15.4% | 17.3% | 19.2% | 20.2% | |
| 12.0% | 12.0% | 11.2% | 11.8% | 13.5% | 14.9% |
Balance sheet
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 1,166 | 1,199 | 1,625 | 1,597 | 1,575 | 1,686 |
| Cash | 85 | 103 | 67 | 64 | 50 | 75 |
| Total debt | – | – | 461 | 330 | 208 | 181 |
| Total liabilities | 338 | 322 | 686 | 543 | 425 | 429 |
| 828 | 877 | 938 | 1,054 | 1,150 | 1,257 | |
| 33 | 33 | 32 | 32 | 33 | 33 | |
| 10.6% | 11.5% | 8.1% | 9.1% | 10.6% | 11.5% | |
| 10.2% | 11.0% | 11.2% | 10.3% | 11.2% | 12.3% |
Cash flow
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 150 | 161 | 139 | 184 | 182 | 217 | |
| 32 | 36 | 50 | 38 | 36 | 43 | |
| 118 | 124 | 89 | 146 | 146 | 173 | |
| Dividends paid | 17 | 19 | 21 | 23 | 26 | 28 |
| 13 | 35 | 35 | 4 | 6 | 108 | |
| 8 | 11 | 13 | 16 | 17 | 18 |
Valuation
- 35.5×
- 32.9×
- 2.77
- 4.4×
- 5.3×
- 31.7×
- 22.0×
- 3.2%
- 2.8%
- 0.6%
Profitability
- 35.7%
- 20.2%
- 14.9%
- 25.7%
- 11.8%
- 10.1%
- 12.4%
- 9.3%
- 14.4%
- 2.4%
Growth
- +8.1%
- +12.8%
- +18.3%
- +10.6%
- +0.2%
Financial health
- 0.4×
- 0.14
- 10.9%
- 20.5×
- 2.07
- 1.59
- 0.62
How it ranks in Materials
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 25%of 989
Top 24%of 954
Bottom 26%of 773
Top 36%of 933
Top 41%of 988
What analysts expect
- Average price target
- $162.00
- Range
- $162.00 – $162.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 30, 2026 | 1.25 | 1.43 | −12.6% |
| Feb 20, 2026 | 1.31 | 1.29 | +1.6% |
| Oct 21, 2025 | 1.35 | 1.36 | −0.7% |
| Jul 31, 2025 | 1.27 | 1.25 | +1.6% |
| Apr 24, 2025 | 1.22 | 1.25 | −2.4% |
| Feb 21, 2025 | 1.03 | 1.11 | −7.2% |
| Oct 25, 2024 | 1.13 | 1.11 | +1.8% |
| Jul 26, 2024 | 1.09 | 1.03 | +5.8% |
0.6%of the share price, paid each year
On $1,000 invested$6a year at today's yield, before tax
+10.6%2020 to 2025
Raised10 yearsin a row, in our data
Paid per share, each year
$0.34 in 2015 → $0.96 in 2025
How safe it looks
18.3% of its profit
Room to growStretchedMore than it earns: 16.3%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
2/7Passes 2 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
62Pass
Benjamin Graham
76Pass
Philip Fisher
51No pass
Peter Lynch
38No pass
Joel Greenblatt
42No pass
Charlie Munger
44No pass
Terry Smith
48No pass
Questions about Balchem
Is Balchem a good stock to buy?
A solid business, but the price is high. 2 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Balchem AI analysis
What does Balchem do?
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It is in Specialty Chemicals, based in Montvale, NJ, United States, with 1,368 employees.
Does Balchem pay a dividend?
Yes. At today's price the dividend is 0.6% a year, about 18% of its yearly profit. In 2025 it paid out $28.3 million in dividends.
Is Balchem stock halal?
Yes. Balchem passes our halal screen: its business is permitted and its debt is 3% of its market value, under the 30% limit. How we check
How has Balchem stock done over the past year?
Up 9.6% over the past twelve months, to $172.35. It traded between $147.36 and $183.26 and is 6.0% below its high.
Who are Balchem's competitors?
The largest listed companies in the same industry are Linde, L'Air Liquide, Ecolab and The Sherwin-Williams. The peers table on this page compares their profit, growth and price with Balchem's.
Prices: daily closes to Nov 12, 2026. Fundamentals: company reports via invest-like data.